Systemic Inflammatory Index, TIPS and long term mortality

Systemic Inflammatory Index (SII):

The Systemic Inflammatory Index (SII) is a biomarker that reflects systemic inflammation by combining platelet, neutrophil, and lymphocyte counts into a single formula. It is calculated as:

SII = (Platelet count × Neutrophil count) / Lymphocyte count

SII captures the balance between pro-inflammatory and anti-inflammatory components in the body. Elevated SII values indicate heightened systemic inflammatory activation, which is often associated with poor clinical outcomes, particularly in conditions like cirrhosis, cancer, and cardiovascular diseases. In the context of cirrhosis, elevated SII reflects a state of immune dysregulation and inflammation that exacerbates liver deterioration and contributes to mortality.

---

Transjugular Intrahepatic Portosystemic Shunt (TIPS):

TIPS is a minimally invasive procedure used to treat complications of portal hypertension, such as variceal bleeding, refractory ascites, and hepatorenal syndrome, in patients with advanced liver disease (cirrhosis). The procedure involves creating a shunt between the portal vein and hepatic vein to reduce portal pressure. While TIPS is effective in managing portal hypertension-related complications, it carries risks such as hepatic encephalopathy and high long-term mortality due to the underlying liver dysfunction and systemic effects.

---

Short-Term and Long-Term Mortality Associated with TIPS:

1. Short-Term Mortality (≤12 months):

• The study found that the 6-month mortality rate was 4.8%, and the 12-month mortality rate was 7.6%.
• Early mortality is primarily driven by factors such as liver failure, gastrointestinal bleeding, and hepatorenal syndrome.
• Inflammatory markers like SII and neutrophil-to-lymphocyte ratio (NLR) were strong predictors of early mortality, indicating that systemic inflammation plays a critical role in short-term outcomes.

2. Long-Term Mortality (>12 months):

• The 18-month mortality rate was 10.8%.
• Long-term mortality is influenced by the progressive deterioration of liver function and systemic complications. Over time, nutritional depletion (as assessed by the Prognostic Nutritional Index, PNI) becomes a stronger predictor of mortality, highlighting the interplay between inflammation and malnutrition in cirrhotic patients.
• The study demonstrated that the predictive accuracy of SII remains robust in long-term mortality prediction when combined with age and the Child-Pugh score in Nomogram 2.

---

How SII Helps Identify Long-Term Mortality After TIPS:

SII is a powerful prognostic marker because it reflects systemic inflammatory activation, which worsens liver function and contributes to multi-organ failure in cirrhotic patients. The study identified SII as an independent predictor of 18-month mortality post-TIPS, alongside age and the Child-Pugh score. Here's how SII contributes to long-term mortality prediction:

1. Mechanistic Role:

• Elevated SII indicates an imbalance in platelet, neutrophil, and lymphocyte counts, signifying heightened systemic inflammation. This inflammatory state accelerates hepatic deterioration and worsens outcomes in cirrhotic patients.
• SII captures the combined effects of immune dysregulation and inflammation, which are central to the progression of liver disease and mortality.

2. Integration in Prognostic Models:

• The study developed two nomograms to predict 18-month mortality:
• Nomogram 1: Child-Pugh score + SII
• Nomogram 2: Age + Child-Pugh score + SII
• Nomogram 2 demonstrated superior predictive performance, with a C-index of 0.82 and high area under the curve (AUC) values for 6-, 12-, and 18-month mortality prediction.

3. Enhanced Predictive Accuracy:

• Adding SII to traditional prognostic scores like Child-Pugh significantly improved the model's ability to stratify patients into high- and low-risk groups. Net Reclassification Improvement (NRI) and Integrated Discrimination Improvement (IDI) analyses confirmed that SII enhances prognostic accuracy over the Child-Pugh score alone.

4. Temporal Dynamics:

• SII is more effective in predicting early mortality (≤12 months), while nutritional markers like PNI become stronger predictors beyond one year. This indicates shifting pathophysiological dynamics in cirrhotic patients undergoing TIPS.

5. Clinical Utility:

• Decision curve analysis showed that Nomogram 2 (incorporating SII) provides strong net clinical benefit across multiple risk thresholds. This makes SII a valuable tool for individualized mortality risk estimation and early identification of high-risk patients post-TIPS.

---

Conclusion:

SII is a robust systemic inflammatory marker that plays a critical role in predicting both short-term and long-term mortality in cirrhotic patients undergoing TIPS. Its integration into predictive models, alongside age and the Child-Pugh score, enhances risk stratification and supports clinical decision-making. By reflecting the interplay between inflammation and liver dysfunction, SII provides valuable insights into the mechanisms driving mortality and helps identify high-risk patients for early intervention.